nach oben

Herzschrittmachertherapie + Elektrophysiologie

Erschienen in:

01.12.2014 | Schwerpunkt

Komplikationen der Katheterablation von Vorhofflimmern

verfasst von: Dr. Stephan Zellerhoff, Roland R. Tilz, Lars Eckardt

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Zusammenfassung

In den vergangenen Jahren haben der Stellwert der Katheterablation von Vorhofflimmern und parallel die Untersuchungszahlen immer weiter zugenommen. Nachdem initial Daten bezüglich der Komplikationen dieses Eingriffs nur anhand von Umfragen und Berichten einzelner Zentren vorlagen, sind jetzt ICD-Code-basierte Analysen der Komplikationsraten verfügbar: Insgesamt ist die Komplikationsrate im Verlauf der letzten 10 Jahre leicht gestiegen; die Rate an akuten Komplikationen beträgt 6,3 %. Die häufigsten Komplikationen sind kardiale, gefolgt von vaskulären, respiratorischen und neurologischen Komplikationen. Risikofaktoren für eine höhere Komplikationsrate sind ein hohes Alter > 80 Jahre, weibliches Geschlecht sowie weniger routinierte Untersucher bzw. Kliniken.

Neuberger H-R, Tilz RR, Bonnemeier H et al (2013) A survey of German centres performing invasive electrophysiology: structure, procedures, and training positions. Europace. doi:10.1093/europace/eut149

Jaïs P, Haissaguerre M, Shah DC et al (1997) A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 95:572–576. doi:10.1161/01.CIR.95.3.572PubMedCrossRef

Haissaguerre M, Jaïs P, Shah DC et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666.PubMedCrossRef

Haissaguerre M, Jaïs P, Shah DC et al (2000) Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 101:1409–1417.PubMedCrossRef

Robbins IM, Colvin EV, Doyle TP et al (1998) Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation 98:1769–1775.PubMedCrossRef

Oral H, Knight BP, Ozaydin M et al (2002) Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: feasibility and mechanistic insights. Circulation 106:1256–1262.PubMedCrossRef

Oral H, Scharf C, Chugh A et al (2003) Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 108:2355–2360. doi:10.1161/01.CIR.0000095796.45180.88PubMedCrossRef

Arentz T, Weber R, Bürkle G et al (2007) Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Results from a prospective randomized study. Circulation 115:3057–3063. doi:10.1161/CIRCULATIONAHA.107.690578PubMedCrossRef

Wilber DJ, Pappone C, Neuzil P et al (2010) Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 303:333–340. doi:10.1001/jama.2009.2029PubMedCrossRef

10.

Camm AJ, Lip GYH, De Caterina R et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33:2719–2747. doi:10.1093/eurheartj/ehs253PubMedCrossRef

11.

Cappato R, Calkins H, Chen S-A et al (2005) Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111:1100–1105. doi:10.1161/01.CIR.0000157153.30978.67PubMedCrossRef

12.

Cappato R, Calkins H, Chen S-A et al (2010) Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 3:32–38. doi: 10.1161/CIRCEP.109.859116PubMedCrossRef

13.

Deshmukh A, Patel NJ, Pant S et al (2013) Inhospital Complications Associated with Catheter Ablation of Atrial Fibrillation in the United States between 2000–2010: Analysis of 93,801 Procedures. Circulation. doi:10.1161/CIRCULATIONAHA.113.003862

14.

Cappato R, Calkins H, Chen S-A et al (2009) Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol 53:1798–1803. doi:10.1016/j.jacc.2009.02.022PubMedCrossRef

15.

Piccini JP, Sinner MF, Greiner MA et al (2012) Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation. Circulation 126:2200–2207. doi:10.1161/CIRCULATIONAHA.112.109330PubMedCentralPubMedCrossRef

16.

Shah RU, Freeman JV, Shilane D et al (2012) Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol 59:143–149. doi 10.1016/j.jacc.2011.08.068PubMedCrossRef

17.

Ellis ER, Culler SD, Simon AW, Reynolds MR (2009) Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries. Heart Rhythm 6:1267–1273. doi:10.1016/j.hrthm.2009.06.009PubMedCentralPubMedCrossRef

18.

Waigand J, Uhlich F, Gross CM, Thalhammer C, Dietz R (1999) Percutaneous treatment of pseudoaneurysms and arteriovenous fistulas after invasive vascular procedures. Catheter Cardiovasc Interv 47:157–164. doi:10.1002/(SICI)1522-726X(199906)47:2<157::AID-CCD5>3.0.CO;2-YPubMedCrossRef

19.

Ghaye B, Szapiro D, Dacher J-N et al (2003) Percutaneous ablation for atrial fibrillation: the role of cross-sectional imaging. Radiographics 23(Spec No):19–33– discussion S 48–50. doi: 10.1148/rg.23si035513CrossRef

20.

Cappato R, Calkins H, Chen S-A et al (2011) Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: a worldwide report. J Am Coll Cardiol 58:2696–2697. doi:10.1016/j.jacc.2011.09.028PubMedCrossRef

21.

Bunch TJ, Asirvatham SJ, Friedman PA et al (2005) Outcomes after cardiac perforation during radiofrequency ablation of the atrium. J Cardiovasc Electrophysiol 16:1172–1179. doi:10.1111/j.1540-8167.2005.50135.xPubMedCrossRef

22.

Latchamsetty R, Gautam S, Bhakta D et al (2011) Management and outcomes of cardiac tamponade during atrial fibrillation ablation in the presence of therapeutic anticoagulation with warfarin. Heart Rhythm 8:805–808. doi:10.1016/j.hrthm.2011.01.020PubMedCrossRef

23.

Scherr D, Sharma K, Dalal D et al (2009) Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 20:1357–1363. doi:10.1111/j.1540-8167.2009.01540.xPubMedCrossRef

24.

Oral H, Chugh A, Ozaydin M et al (2006) Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 114:759–765. doi:10.1161/CIRCULATIONAHA.106.641225PubMedCrossRef

25.

Dong J, Vasamreddy CR, Jayam V et al (2005) Incidence and predictors of pulmonary vein stenosis following catheter ablation of atrial fibrillation using the anatomic pulmonary vein ablation approach: results from paired magnetic resonance imaging. J Cardiovasc Electrophysiol 16:845–852. doi:10.1111/j.1540-8167.2005.40680.xPubMedCrossRef

26.

Saad EB, Rossillo A, Saad CP et al (2003) Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy. Circulation 108:3102–3107. doi:10.1161/01.CIR.0000104569.96907.7FPubMedCrossRef

27.

Kato R, Lickfett L, Meininger G et al (2003) Pulmonary vein anatomy in patients undergoing catheter ablation of atrial fibrillation: lessons learned by use of magnetic resonance imaging. Circulation 107:2004–2010. doi:10.1161/01.CIR.0000061951.81767.4EPubMedCrossRef

28.

Thomas D, Katus HA, Voss F (2011) Asymptomatic pulmonary vein stenosis after cryoballoon catheter ablation of paroxysmal atrial fibrillation. J Electrocardiol 44:473–476. doi:10.1016/j.jelectrocard.2010.09.007PubMedCrossRef

29.

Mansour M, Holmvang G, Sosnovik D et al (2004) Assessment of pulmonary vein anatomic variability by magnetic resonance imaging: implications for catheter ablation techniques for atrial fibrillation. J Cardiovasc Electrophysiol 15:387–393. doi:10.1046/j.1540-8167.2004.03515.xPubMedCrossRef

30.

Baranowski B, Saliba W (2011) Our Approach to Management of Patients With Pulmonary Vein Stenosis Following AF Ablation. J Cardiovasc Electrophysiol 22:364–367. doi:10.1111/j.1540-8167.2010.01981.xPubMedCrossRef

31.

Neumann T, Kuniss M, Conradi G et al (2009) Pulmonary vein stenting for the treatment of acquired severe pulmonary vein stenosis after pulmonary vein isolation: clinical implications after long-term follow-up of 4 years. J Cardiovasc Electrophysiol 20:251–257. doi:10.1111/j.1540-8167.2008.01316.xPubMedCrossRef

32.

De Potter TJR, Schmidt B, Chun KRJ et al (2011) Drug-eluting stents for the treatment of pulmonary vein stenosis after atrial fibrillation ablation. Europace 13:57–61. doi:10.1093/europace/euq419PubMedCrossRef

33.

Sánchez-Quintana D, Cabrera J-A, Climent V et al (2005) How close are the phrenic nerves to cardiac structures? Implications for cardiac interventionalists. J Cardiovasc Electrophysiol 16:309–313. doi:10.1046/j.1540-8167.2005.40759.xPubMedCrossRef

34.

Sarabanda AV, Bunch TJ, Johnson SB et al (2005) Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. J Am Coll Cardiol 46:1902–1912. doi:10.1016/j.jacc.2005.07.046PubMedCrossRef

35.

Bunch TJ, Bruce GK, Mahapatra S et al (2005) Mechanisms of phrenic nerve injury during radiofrequency ablation at the pulmonary vein orifice. J Cardiovasc Electrophysiol 16:1318–1325. doi:10.1111/j.1540-8167.2005.00216.xPubMedCrossRef

36.

Packer DL, Kowal RC, Wheelan KR et al (2013) Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol 61:1713–1723. doi:10.1016/j.jacc.2012.11.064PubMedCrossRef

37.

Kuck K-H, Fürnkranz A (2010) Cryoballoon ablation of atrial fibrillation. J Cardiovasc Electrophysiol 21:1427–1431. doi:10.1111/j.1540-8167.2010.01944.xPubMedCrossRef

38.

Sacher F, Monahan KH, Thomas SP et al (2006) Phrenic nerve injury after atrial fibrillation catheter ablation: characterization and outcome in a multicenter study. J Am Coll Cardiol 47:2498–2503. doi:10.1016/j.jacc.2006.02.050PubMedCrossRef

39.

Sánchez-Quintana D, Cabrera J-A, Climent V et al (2005) Anatomic relations between the esophagus and left atrium and relevance for ablation of atrial fibrillation. Circulation 112:1400–1405. doi:10.1161/CIRCULATIONAHA.105.551291PubMedCrossRef

40.

Metzner A, Burchard A, Wohlmuth P et al (2013) Increased incidence of esophageal thermal lesions using the second-generation 28 mm cryoballoon. Circ Arrhythm Electrophysiol. doi:10.1161/CIRCEP.113.000228

41.

Tilz RR, Chun KRJ, Metzner A et al (2010) Unexpected high incidence of esophageal injury following pulmonary vein isolation using robotic navigation. J Cardiovasc Electrophysiol 21:853–858. doi:10.1111/j.1540-8167.2010.01742.xPubMed

42.

Metzner A, Schmidt B, Fuernkranz A et al (2011) Esophageal temperature change and esophageal thermal lesions after pulmonary vein isolation using the novel endoscopic ablation system. Heart Rhythm 8:815–820. doi:10.1016/j.hrthm.2011.01.022PubMedCrossRef

43.

Martinek M, Meyer C, Hassanein S et al (2010) Identification of a high-risk population for esophageal injury during radiofrequency catheter ablation of atrial fibrillation: procedural and anatomical considerations. Heart Rhythm 7:1224–1230. doi:10.1016/j.hrthm.2010.02.027PubMedCrossRef

44.

Zellerhoff S, Lenze F, Eckardt L (2011) Prophylactic proton pump inhibition after atrial fibrillation ablation: is there any evidence? Europace 13:1219–1221. doi:10.1093/europace/eur139PubMedCrossRef

45.

Ahmed H, Neuzil P, d’Avila A et al (2009) The esophageal effects of cryoenergy during cryoablation for atrial fibrillation. Heart Rhythm 6:962–969. doi:10.1016/j.hrthm.2009.03.051PubMedCrossRef

46.

Zellerhoff S, Ullerich H, Lenze F et al (2010) Damage to the esophagus after atrial fibrillation ablation: Just the tip of the iceberg? High prevalence of mediastinal changes diagnosed by endosonography. Circ Arrhythm Electrophysiol 3:155–159. doi:10.1161/CIRCEP.109.915918PubMedCrossRef

47.

Martinek M, Hassanein S, Bencsik G et al (2009) Acute development of gastroesophageal reflux after radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm. doi:10.1016/j.hrthm.2009.06.022

48.

Halm U, Gaspar T, Zachäus M et al (2010) Thermal esophageal lesions after radiofrequency catheter ablation of left atrial arrhythmias. Am J Gastroenterol 105:551–556. doi:10.1038/ajg.2009.625PubMedCrossRef

49.

Nair GM, Nery PB, Redpath CJ et al (2014) Atrioesophageal Fistula in the Era of Atrial Fibrillation Ablation: A Review. Can J Cardiol 30:388–395. doi:10.1016/j.cjca.2013.12.012PubMedCrossRef

50.

Eitel C, Rolf S, Zachäus M et al (2013) Successful nonsurgical treatment of esophagopericardial fistulas after atrial fibrillation catheter ablation: a case series. Circ Arrhythm Electrophysiol 6:675–681. doi:10.1161/CIRCEP.113.000384PubMedCrossRef

51.

Deneke T, Schade A, Diegeler A, Nentwich K (2014) Esophago-pericardial fistula complicating atrial fibrillation ablation using a novel irrigated radiofrequency multipolar ablation catheter. J Cardiovasc Electrophysiol 25:442–443. doi:10.1111/jce.12308PubMedCrossRef

52.

Zellerhoff S, Lenze F, Schulz R, Eckardt L (2011) Fatal course of esophageal stenting of an atrioesophageal fistula after atrial fibrillation ablation. Heart Rhythm 8:624–626. doi:10.1016/j.hrthm.2010.10.041PubMedCrossRef

53.

Singh SM, d’Avila A, Singh SK et al (2013) Clinical outcomes after repair of left atrial esophageal fistulas occurring after atrial fibrillation ablation procedures. Heart Rhythm. doi:10.1016/j.hrthm.2013.08.012

54.

Singh SM, d’Avila A, Doshi SK et al (2008) Esophageal injury and temperature monitoring during atrial fibrillation ablation. Circ Arrhythm Electrophysiol 1:162–168. doi:10.1161/CIRCEP.107.789552PubMedCrossRef

55.

Fürnkranz A, Bordignon S, Schmidt B et al (2013) Luminal esophageal temperature predicts esophageal lesions after second-generation cryoballoon pulmonary vein isolation. Heart Rhythm 10:789–793. doi:10.1016/j.hrthm.2013.02.021PubMedCrossRef

56.

Buch E, Nakahara S, Shivkumar K (2008) Intra-pericardial balloon retraction of the left atrium: a novel method to prevent esophageal injury during catheter ablation. Heart Rhythm 5:1473–1475. doi:10.1016/j.hrthm.2008.06.023PubMedCentralPubMedCrossRef

57.

Sullivan T, Lau DH, Roberts-Thomson KC et al (2013) Complications of catheter ablation of atrial fibrillation: a systematic review. Circ Arrhythm Electrophysiol 6:1082–1088. doi:10.1161/CIRCEP.113.000768PubMedCrossRef

Titel: Komplikationen der Katheterablation von Vorhofflimmern
verfasst von: Dr. Stephan Zellerhoff
Roland R. Tilz
Lars Eckardt
Publikationsdatum: 01.12.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 4/2014
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI: https://doi.org/10.1007/s00399-014-0343-5

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Komplikationen der Katheterablation von Vorhofflimmern

Zusammenfassung

Neu im Fachgebiet Kardiologie

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Darf man die Behandlung eines Neonazis ablehnen?

Update Kardiologie

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2014

Katheterablation von paroxysmalem Vorhofflimmern – aktuelle Aspekte

Katheterablation von Vorhofflimmern 2014

Fortschritte der Kryoballon-Technik

Antiarrhythmic therapy of atrial fibrillation: are we treating too late?

Langzeitergebnisse der Katheterablation von Vorhofflimmern

Body surface potential mapping for mapping and treatment of persistent atrial fibrillation

Neu im Fachgebiet Kardiologie

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Darf man die Behandlung eines Neonazis ablehnen?

Update Kardiologie